Glaucoma device showdown ends early: only 10 patients enrolled

NCT ID NCT04658095

Terminated Disease control Sponsor: Sight Sciences, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to compare two surgical devices—the OMNI system and the iStent inject—for lowering eye pressure in people with open-angle glaucoma who already had cataract surgery. The trial was terminated early and only enrolled 10 participants, so results are limited. Both devices are designed to help control glaucoma, not cure it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA, OPEN-ANGLE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLAUCOMA, OPEN-ANGLE

Contacts and locations

Locations

BurgerHospital

Frankfurt, Germany
Institut Catala de Retina (ICR)

Barcelona, 08022, Spain
Manchester Royal Eye Hospital

Manchester, M13, United Kingdom
Paseo Isabel la Católica 1-3. Edificio general Hospital Miguel Servet. Planta calle

Zaragoza, 50009, Spain
Universidad Complutense de Madrid

Valencia, 46026, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.